First Trust Advisors LP cut its stake in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 40.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,548 shares of the company’s stock after selling 17,841 shares during the period. First Trust Advisors LP’s holdings in Medidata Solutions were worth $1,682,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. Polen Capital Management LLC purchased a new stake in Medidata Solutions during the third quarter valued at approximately $205,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Medidata Solutions by 48.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock valued at $205,000 after purchasing an additional 1,056 shares during the period. Zions Bancorporation purchased a new stake in Medidata Solutions during the third quarter valued at approximately $256,000. Pacer Advisors Inc. raised its position in Medidata Solutions by 25.9% during the third quarter. Pacer Advisors Inc. now owns 6,508 shares of the company’s stock valued at $508,000 after purchasing an additional 1,338 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new stake in Medidata Solutions during the third quarter valued at approximately $585,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

How to Become a New Pot Stock Millionaire

In related news, CEO Tarek Sherif sold 26,836 shares of the stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $70.25, for a total value of $1,885,229.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Rouven Bergmann sold 2,000 shares of the stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $66.46, for a total value of $132,920.00. Following the completion of the transaction, the chief financial officer now directly owns 87,775 shares in the company, valued at approximately $5,833,526.50. The disclosure for this sale can be found here. In the last three months, insiders sold 35,836 shares of company stock worth $2,495,689. 5.80% of the stock is owned by insiders.

A number of brokerages have issued reports on MDSO. Morgan Stanley decreased their price objective on Medidata Solutions from $86.00 to $79.00 and set an “overweight” rating on the stock in a research report on Friday, February 9th. ValuEngine cut Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Thursday, March 1st. TheStreet raised Medidata Solutions from a “c+” rating to a “b-” rating in a research note on Monday, March 12th. Zacks Investment Research raised Medidata Solutions from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a research note on Wednesday, February 14th. Finally, Deutsche Bank initiated coverage on Medidata Solutions in a research note on Friday, December 8th. They set a “buy” rating and a $78.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eleven have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $82.07.

Medidata Solutions Inc (NASDAQ:MDSO) opened at $64.99 on Friday. The company has a market capitalization of $3,972.77, a P/E ratio of 77.09, a PEG ratio of 3.53 and a beta of 1.56. Medidata Solutions Inc has a 52 week low of $54.91 and a 52 week high of $85.92. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.49 and a current ratio of 1.49.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.10. Medidata Solutions had a return on equity of 11.59% and a net margin of 8.14%. The company had revenue of $141.20 million for the quarter, compared to analysts’ expectations of $140.65 million. During the same quarter in the prior year, the firm earned $0.33 earnings per share. Medidata Solutions’s revenue was up 13.4% compared to the same quarter last year. sell-side analysts forecast that Medidata Solutions Inc will post 0.93 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “First Trust Advisors LP Sells 17,841 Shares of Medidata Solutions Inc (MDSO)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/first-trust-advisors-lp-sells-17841-shares-of-medidata-solutions-inc-mdso/1959468.html.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.